These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3435692)

  • 1. Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.
    Chan E; Aarons L; Serlin M; Breckenridge A; Rowland M
    Br J Clin Pharmacol; 1987 Nov; 24(5):621-5. PubMed ID: 3435692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potentiation of warfarin anticoagulation by amiodarone.
    Hamer A; Peter T; Mandel WJ; Scheinman MM; Weiss D
    Circulation; 1982 May; 65(5):1025-9. PubMed ID: 7074739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
    Mosterd JJ; Thijssen HH
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats.
    Vainieri H; Wingard LB
    J Pharmacol Exp Ther; 1977 May; 201(2):507-17. PubMed ID: 870684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemical basis of warfarin therapy.
    Suttie JW
    Adv Exp Med Biol; 1987; 214():3-16. PubMed ID: 3310547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.
    Choonara IA; Malia RG; Haynes BP; Hay CR; Cholerton S; Breckenridge AM; Preston FE; Park BK
    Br J Clin Pharmacol; 1988 Jan; 25(1):1-7. PubMed ID: 3370190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dose-dependent effect of BHT (butylated hydroxytoluene) on vitamin K-dependent blood coagulation in rats.
    Cottrell S; Andrews CM; Clayton D; Powell CJ
    Food Chem Toxicol; 1994 Jul; 32(7):589-94. PubMed ID: 8045471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.
    Ooi QX; Wright DFB; Tait RC; Isbister GK; Duffull SB
    Clin Pharmacokinet; 2017 Dec; 56(12):1555-1566. PubMed ID: 28409488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of thrombogenicity of activated and non-activated prothrombin concentrates in a rat model.
    Silberman S; Fareed J; Walenga J
    Br J Exp Pathol; 1986 Aug; 67(4):597-604. PubMed ID: 3091059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant effects of warfarin and kinetics of K vitamins in blood and feces.
    Nakamura K; Toyohira H; Kariyazono H; Ishibashi M; Saigenji H; Shimokawa S; Taira A
    Artery; 1994; 21(3):148-60. PubMed ID: 7794122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony.
    Scott EA; Sandler GA; Byars TD
    Am J Vet Res; 1978 Dec; 39(12):1888-91. PubMed ID: 749570
    [No Abstract]   [Full Text] [Related]  

  • 12. The contribution of plasma (R)- & (S)-warfarin and vitamin K concentrations to intra-individual variability in anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Feb; 83(2):349-50. PubMed ID: 10739399
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy.
    Bern M
    JPEN J Parenter Enteral Nutr; 2004; 28(6):388-98. PubMed ID: 15568285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rodenticide effect of warfarin. 1. Effect on blood coagulation].
    Niedner R; Kayser M; Meyer F
    Arzneimittelforschung; 1974 May; 24(5):802-6. PubMed ID: 4408104
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A; Rao LV; Rapaport SI
    J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease.
    Goldschmidt B
    Acta Paediatr Acad Sci Hung; 1970; 11(2):135-9. PubMed ID: 5504583
    [No Abstract]   [Full Text] [Related]  

  • 17. Warfarin anticoagulation in the horse.
    Scott EA; Byars TD; Lamar AM
    J Am Vet Med Assoc; 1980 Dec; 177(11):1146-51. PubMed ID: 7440316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation by warfarin of "template" bleeding time in rats: a vitamin K-dependent effect.
    Reyers I; de Gaetano G; Donati MB
    Proc Soc Exp Biol Med; 1986 Feb; 181(2):275-6. PubMed ID: 3945636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.